IT1263957B - Impiego terapeutico del pirrolidon carbossilato di piridossina - Google Patents

Impiego terapeutico del pirrolidon carbossilato di piridossina

Info

Publication number
IT1263957B
IT1263957B ITMI930341A ITMI930341A IT1263957B IT 1263957 B IT1263957 B IT 1263957B IT MI930341 A ITMI930341 A IT MI930341A IT MI930341 A ITMI930341 A IT MI930341A IT 1263957 B IT1263957 B IT 1263957B
Authority
IT
Italy
Prior art keywords
carboxylate
pyrolidon
pyridoxy
therapeutic use
fatty acids
Prior art date
Application number
ITMI930341A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ITMI930341A priority Critical patent/IT1263957B/it
Publication of ITMI930341A0 publication Critical patent/ITMI930341A0/it
Priority to TW082104060A priority patent/TW230749B/zh
Priority to PCT/EP1994/000518 priority patent/WO1994018965A1/en
Publication of ITMI930341A1 publication Critical patent/ITMI930341A1/it
Application granted granted Critical
Publication of IT1263957B publication Critical patent/IT1263957B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

La somministrazione di pirrolidon carbossilato di piridossina consente di inibire la formazione di esteri etilici degli acidi grassi liberi ed il loro accumulo negli organi animali, nonché di compensare alterazioni delle funzioni enzimatiche connesse con gli acidi grassi liberi ed i loro esteri.
ITMI930341A 1993-02-23 1993-02-23 Impiego terapeutico del pirrolidon carbossilato di piridossina IT1263957B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITMI930341A IT1263957B (it) 1993-02-23 1993-02-23 Impiego terapeutico del pirrolidon carbossilato di piridossina
TW082104060A TW230749B (it) 1993-02-23 1993-05-22
PCT/EP1994/000518 WO1994018965A1 (en) 1993-02-23 1994-02-19 Therapeutic use of pyridoxine pyrrolidone carboxylate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930341A IT1263957B (it) 1993-02-23 1993-02-23 Impiego terapeutico del pirrolidon carbossilato di piridossina

Publications (3)

Publication Number Publication Date
ITMI930341A0 ITMI930341A0 (it) 1993-02-23
ITMI930341A1 ITMI930341A1 (it) 1994-08-23
IT1263957B true IT1263957B (it) 1996-09-05

Family

ID=11365120

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI930341A IT1263957B (it) 1993-02-23 1993-02-23 Impiego terapeutico del pirrolidon carbossilato di piridossina

Country Status (3)

Country Link
IT (1) IT1263957B (it)
TW (1) TW230749B (it)
WO (1) WO1994018965A1 (it)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
AU763464B2 (en) 1999-03-08 2003-07-24 Medicure Inc. Pyridoxal analogues for vitamin B-6 disorders
CA2376029A1 (en) 1999-07-13 2001-01-18 Medicure Inc. Use of pyridoxin derivatives for the treatment of diabetes and related complications
JP2003528146A (ja) 2000-03-28 2003-09-24 メディキュア インターナショナル インコーポレイテッド 脳血管疾患の治療
IL187159A0 (en) * 2007-07-03 2009-02-11 Gur Megiddo Use of metadoxine in relief of alcohol intoxication
AU2007362353A1 (en) * 2007-12-12 2009-06-18 Northern Innovations And Formulations Corp. Preparations containing pyridoxine and alpha-hydroxyisocaproic acid (HICA)
WO2010013242A1 (en) 2008-07-29 2010-02-04 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
JP5770173B2 (ja) 2009-06-25 2015-08-26 アルコブラ、リミテッドＡｌｃｏｂｒａ Ｌｔｄ． 認知疾患、障害または病態の治療、症状緩和、軽減、改善および予防方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2485372B1 (fr) * 1980-06-30 1985-08-09 Baldacci Lab Spa Composition pharmaceutique pour le traitement des etats d'intoxication alcoolique aigue a base de 5-oxo-2-pyrrolidone carboxylate de pyridoxine et procede de preparation de ce dernier

Also Published As

Publication number Publication date
ITMI930341A0 (it) 1993-02-23
WO1994018965A1 (en) 1994-09-01
TW230749B (it) 1994-09-21
ITMI930341A1 (it) 1994-08-23

Similar Documents

Publication Publication Date Title
PT1239849E (pt) Formulacoes farmaceuticas que compreendem resveratrol e a sua utilizacao
DE3850109D1 (de) 13-trans-retinsäureester.
ES2145118T3 (es) Derivados de acidos grasos y composiciones farmaceuticas que los contienen.
AR007989A1 (es) Un metodo para reducir el nivel de lipidos en el suero, colesterol y/o trigliceridos y tratar enfermedades relacionadas en una especie de mamiferosmediante una combinacion de un inhibidor de las proteinas de transferencia de trigliceridos microsomales (mtp) y otro agente de reduccion del colesterol, y
DE60116625D1 (de) Therapeutische kombinationen von fettsäuren
SE8702980D0 (sv) Therapeutic use of serotonin antagonists
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
ES2181993T3 (es) Composiciones para el cuidado de la piel que contienen retinol o ester de retinilo.
AU4180593A (en) The use of complement inhibitors for the preparation of a pharmaceutical for the prophylaxis and therapy of inflammatory intestinal and skin disorders as well as purpura
DE3778699D1 (de) Verwendung von vitamin e zur herstellung von arzneimitteln zur normalisierung der blutgerinnung bei therapie mit hochungesaettigten fettsaeuren vom omega-3-typ.
DE50010931D1 (de) Substituierte benzimidazole
DE58906676D1 (de) Ester des Retinols und/oder der Retinsäure enthaltende Aerosol-Inhalate.
ES2059880T3 (es) Utilizacion del acido estearidonico para el tratamiento de las enfermedades inflamatorias.
WO1995013071A3 (en) Treatment of immunoregulatory disorders
IT1263957B (it) Impiego terapeutico del pirrolidon carbossilato di piridossina
ES2107707T3 (es) Empleo de esteres de l-carnitina y acil l-carnitina con hidroxiacidos para produccion de composiciones farmaceuticas para el tratamiento de dermatosis.
SE9704693D0 (sv) Method of the prophylactic treatment of mastitis
ES2188663T3 (es) Uso de productos que contienen magnesio para el tratamiento o profilaxis de enfermedades neoplasicas o autoinmunes.
MX9400630A (es) 6-cloro-5-fluoro-3-(2-tenoil)-2-oxindol-1-carboxamida como un agente analgesico y antiinflamatorio.
ATE135909T1 (de) Verfahren zur behandlung von akne
IT8023656A0 (it) Procedimento per la produzione dell'enzima colesterolo-esterasi eper idrolisi degli esteri con acidi grassi del colesterolo mediante l'impiego dell'enzima stesso.
ATE116849T1 (de) Pharmazeutische verwendung von fettsäuren.
ES2072666T3 (es) Esteres de acidos n-alquil 1,4-dihidropiridindicarboxilicos.
AR007369A1 (es) El uso de derivados carboxilados y un medicamento que contiene uno o mas de dichos derivados
ATE269065T1 (de) Behandlung von verdauungsstörungen

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970227